bioMérieux receives U.S. FDA Special 510(k) clearance and CLIA-waiver for its BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini

26 Jun 2024 07:01 CEST

Subscribe
Issuer

BIOMERIEUX

See attachment(s) / Voir document(s) joint(s) / Zie bijlage / Ver documento(s) em anexo

16165_1265305_PR_bioMerieux_SPOTFIRE_RST_Panel_Mini_FDA_Clearance_20240626.pdf

Source

BIOMERIEUX

Provider

Les Echos

Company Name

BIOMERIEUX

ISIN

FR0013280286

Symbol

BIM

Market

Euronext

Attachments

  • Original Link
  • Permalink

Disclaimer

BioMérieux SA published this content on 26 June 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 26 June 2024 05:06:25 UTC.